Sensorion Stock OTC Markets
Stocks
SENOF
FR0012596468
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 134M 155M 123M 115M 216M 14.73B 220M 1.46B 568M 7.17B 582M 569M 24.82B | P/E Ratio 2026 * |
-17.3x | P/E Ratio 2027 * | -4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.83M 2.12M 1.68M 1.58M 2.95M 201M 3M 19.88M 7.75M 97.87M 7.94M 7.77M 339M | EV / Sales 2026 * |
0.08x | EV / Sales 2027 * | 20.9x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 155M | |
| +1.51% | +1.84% | -12.12% | -11.74% | 43.03B | |
| +3.11% | +3.11% | +279.08% | +509.39% | 32.71B | |
| +0.22% | -1.08% | +15.66% | -14.70% | 30.29B | |
| +1.62% | -2.08% | -1.91% | +27.08% | 29.4B | |
| +4.09% | +0.93% | +12.97% | +20.66% | 25.08B | |
| +1.14% | +3.62% | - | - | 13.54B | |
| -1.63% | +2.88% | +56.69% | +114.08% | 13.35B | |
| +0.53% | -0.65% | +5.26% | +6.79% | 12.97B | |
| -0.74% | -1.62% | +105.89% | +79.51% | 12.11B | |
| Average | +1.00% | +1.45% | +57.69% | +91.38% | 23.61B | |
| Weighted average by Cap. | +1.50% | +1.48% | +57.60% | +98.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 25.31M 20.14M 18.85M 35.33M 2.41B 35.88M 238M 92.73M 1.17B 94.98M 92.96M 4.05B | 6.4M 7.4M 5.89M 5.52M 10.34M 704M 10.5M 69.58M 27.13M 343M 27.79M 27.2M 1.19B |
| Net income | -4.34M -5.02M -4M -3.74M -7.02M -478M -7.12M -47.22M -18.41M -232M -18.86M -18.46M -805M | -50.64M -58.63M -46.66M -43.68M -81.86M -5.57B -83.13M -551M -215M -2.71B -220M -215M -9.39B |
| Net Debt | -132M -153M -122M -114M -213M -14.53B -217M -1.44B -560M -7.07B -574M -561M -24.48B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
- SENOF Stock
Select your edition
All financial news and data tailored to specific country editions
